Get the Stockscreener App
0.6939
4.57%
-0.0332
Pre-market:
.69
-0.0039
-0.56%
Fractyl Health Inc stock is traded at $0.6939, with a volume of 1.79M.
It is down -4.57% in the last 24 hours and up +52.20% over the past month.
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
See More
Previous Close:
$0.7271
Open:
$0.7389
24h Volume:
1.79M
Relative Volume:
0.54
Market Cap:
$110.09M
Revenue:
$3,000
Net Income/Loss:
$-140.95M
P/E Ratio:
-0.3393
EPS:
-2.0449
Net Cash Flow:
$-90.89M
1W Performance:
+5.73%
1M Performance:
+52.20%
6M Performance:
-38.59%
1Y Performance:
-57.43%
1-Day Range:
$0.6666
$0.746
1-Week Range:
$0.5841
$0.7511
52-Week Range:
$0.3772
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.6939 | 110.09M | 3,000 | -140.95M | -90.89M | -2.0449 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-15-25 | Initiated | H.C. Wainwright | Buy |
| Aug-28-25 | Initiated | Ladenburg Thalmann | Buy |
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
View All
Fractyl Health Inc Stock (GUTS) Latest News
Fractyl Health to Report First Quarter 2026 Financial - GlobeNewswire
GUTS Stock Price, Quote & Chart | FRACTYL HEALTH INC (NASDAQ:GUTS) - ChartMill
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Down 34.7% in April - MarketBeat
Fractyl Health, Inc. (GUTS) loses 77.6% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Why did GUTS stock plummet today despite positive gut therapy midterm study? - MSN
Fractyl Health plummets on data for Revita for weight loss maintenance - MSN
Fractyl Health Sinks After-Hours On Stock Offering, But Investors Cheer Durable Weight Loss Data - MSN
[ARS] FRACTYL HEALTH, INC. SEC Filing - Stock Titan
Fractyl Health (NASDAQ: GUTS) details 2026 meeting, board votes and pay - Stock Titan
Fractyl Health's (GUTS) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
HC Wainwright & Co. Initiates Coverage of Fractyl Health (GUTS) with Buy Recommendation - MSN
GUTS (Fractyl Health Inc.) posts far narrower Q4 2025 loss than expected, shares drop 4.81% in today's trading.Expert Breakout Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Fractyl Health (GUTS) stock jumps 21% after hours: Here's what you should know - MSN
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Fractyl Health (NASDAQ:GUTS) Stock Price Up 1.1%Here's Why - MarketBeat
Is Fractyl Health (GUTS) stock breaking out (-4.79%) 2026-04-20Hot Community Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Fractyl Health (GUTS) Stock: Why Restructuring Benefit (Falls) 2026-04-16Pro Level Trade Signals - Cổng thông tin điện tử Tỉnh Sơn La
Buy Signal: Is Fractyl Health Inc undervalued by DCF analysisDip Buying & Low Volatility Stock Recommendations - baoquankhu1.vn
GUTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Fractyl Health Q4 2025 Earnings Call Transcript - MarketBeat
Portfolio Shifts: Is Fractyl Health Inc undervalued by DCF analysis2026 Volatility Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
What chart pattern is Fractyl Health (GUTS) Stock forming | Price at $0.46, Down 2.13%Swing Signals - Xã Châu Thành
Fractyl Health, Inc. (GUTS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
If You Invested $1,000 in Fractyl Health (GUTS) - Stock Titan
Pharma News: Is Fractyl Health Inc benefiting from interest rate changes2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday - MarketBeat
Fractyl Health Earnings Call: Revita Nears Key Pivotal Test - The Globe and Mail
Scalable Biotech Manufacturing Unlocks a $14B Market - Benzinga
HC Wainwright Forecasts Fractyl Health Q1 Earnings - marketbeat.com
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merck & Company (MRK) and Abbott Laboratories (ABT) - The Globe and Mail
Market Recap: Is Fractyl Health Inc in a long term uptrend2026 Volume & Low Risk High Reward Ideas - baoquankhu1.vn
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Decreases By 55.7% - MarketBeat
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Canaccord Genuity Group - MarketBeat
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS) and Terns Pharmaceuticals (TERN) - The Globe and Mail
Fractyl Health FY2029 EPS Forecast Lifted by HC Wainwright - MarketBeat
Fractyl Health Faces Significant Compliance Risks Under Global Anti-Corruption and Sanctions Laws - TipRanks
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):